Influences on Oncologists’ Adoption of New Agents in Adjuvant Chemotherapy of Breast Cancer

Little is known about how oncologists' adopt new treatments for breast cancer. This study investigated influences on oncologists' adoption of paclitaxel as adjuvant chemotherapy for early-stage breast cancer, 9 months after presentation of phase III data suggesting improved disease-free an...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical oncology 2001-02, Vol.19 (4), p.954-959
Hauptverfasser:	BUBAN, Gina M, LINK, Brian K, DOUCETTE, William R
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Biological and medical sciences Breast Neoplasms - drug therapy Chemotherapy Chemotherapy, Adjuvant - psychology Clinical Trials, Phase III as Topic Female Humans Medical sciences Models, Psychological Paclitaxel - administration & dosage Pharmacology. Drug treatments Practice Patterns, Physicians
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!